의료용 보호복 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the medical protective clothing market size is expected to grow from USD 593.95 million in 2025 to USD 630.34 million in 2026 and is forecast to reach USD 872.93 million by 2031 at 6.73% CAGR over 2026-2031.

This report is Segmented by Product Type (Medical Scrubs, Surgical Gowns, Isolation and Patient Gowns, and More), Usability (Disposable, Reusable), End User (Hospitals, and More), Material (Polypropylene, and More), Risk Level (Minimal, and More), Distribution (Direct, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Medical Protective Clothing Market Trends and Insights

Rising Infection Control Protocols: Structural Gown Demand Below the Headline

Healthcare-associated infection exposure is not a temporary event for hospitals, and it continues to renew demand for gowns, scrubs, and other barrier apparel within the medical protective clothing market. The CDC stated that 1 in 31 hospital patients in the United States had at least 1 healthcare-associated infection on any given day, which keeps infection prevention at the center of routine purchasing decisions. This pressure is reinforced by accreditation and operating standards that require documented protective clothing use in clinical settings. Ambulatory surgical centers are also absorbing more procedural work, and that keeps protective garment demand tied closely to procedure counts rather than only to bed capacity. Procurement teams in these settings often prefer standardized packs built around the needs of specific procedures, which shifts supplier competition away from simple unit pricing. The medical protective clothing market therefore benefits when suppliers can match barrier performance, regulatory fit, and dependable replenishment in the same offer.

Expansion of Outpatient and Same-Day Surgical Volumes: Demand Migration, Not Demand Growth

The shift toward outpatient and same-day care is changing where protective garments are purchased within the medical protective clothing market. Demand is moving from inpatient hospitals into ambulatory sites and specialty facilities that operate with different buying patterns and different inventory needs. These buyers often favor procedure-specific packs that bundle gowns, drapes, and accessories into a single orderable format, which can lower per-unit visibility but raise switching costs once a vendor is approved. Ansell reported that its cleanroom and surgical segment posted 2.8% organic constant currency growth in the first half of FY26, which aligns with steady volume expansion in controlled and procedure-heavy settings. This setting rewards vendors that can combine credentialed products with reliable lead times and repeat ordering support. The medical protective clothing market is therefore gaining from care migration even when the total number of procedures does not rise at the same pace.

Polypropylene and Cotton Price Volatility: Margin Compression at the Manufacturing Layer

The medical protective clothing market remains exposed to input swings because polypropylene and cotton still anchor a large share of current product formats. Polypropylene is tied to petrochemical cost movements, and that creates earnings pressure for suppliers that depend heavily on disposable nonwoven output. The problem is sharper in fixed-price institutional contracts because manufacturers often cannot pass cost increases through until the next tender cycle. Cotton exposure adds a second layer of uncertainty for reusable lines that rely on wash durability, wearer comfort, and fiber availability. This cost pressure favors suppliers with broader portfolios because they can balance disposable demand with reusable products and mixed-material offerings. The medical protective clothing market therefore rewards manufacturers that manage procurement risk and material mix with more discipline than smaller single-format competitors.

Other drivers and restraints analyzed in the detailed report include:

1. Demand for Fluid-Impervious and Antimicrobial Textile Structures: Beyond Barrier Performance
2. Growth of Adaptive Garments for Geriatric and Bariatric Care: The Underwritten Demographic Dividend
3. Disposal Compliance and Medical Textile Waste Scrutiny: A Regulatory Gray Zone Narrowing

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Surgical gowns held 33.21% of the medical protective clothing market share in 2025, and that position reflected their required use in sterile operating environments and their direct link to infection control practice. Demand remained concentrated in hospitals and procedure-heavy settings where regulatory compliance and barrier performance are closely monitored. Medline stated that its surgical gowns were used in over 40% of U.S. operating rooms and supported more than 20 million procedures annually, which shows how deep supplier relationships can reinforce incumbent positions in this category. Isolation and patient gowns served broader ward, diagnostic, and outpatient use cases where volumes were high but unit value was lower. Protective coveralls and hazmat suits remained more specialized and were tied to chemical, biological, and controlled high-risk environments.

Compression and support garments are projected to grow at 7.14% through 2031, which makes them the fastest-growing product category in the medical protective clothing market. Their expansion is being supported by standardized recovery protocols for bariatric, orthopedic, and vascular patients across hospitals and longer-term care settings. Lab coats remained stable because diagnostic and academic use patterns were consistent and replacement needs were routine. Caps, masks, and shoe covers continued to move through volume-led procurement channels where pricing power was limited. Cleanroom apparel stayed smaller in volume, but it carried higher unit values because pharmaceutical and biopharma production sites require stricter particle control, and Ansell reported 2.8% organic constant currency growth in its cleanroom segment in FY26 H1.

Disposable products accounted for 72.83% of the usability segment in 2025, which reflected the appeal of simplified infection control workflows and the absence of laundering requirements. Smaller facilities especially favored disposable formats because they did not need to manage sterilization capacity, textile tracking, or outsourced reprocessing contracts. Reusable formats still gained more attention because procurement teams were reassessing total lifecycle cost instead of looking only at first-purchase price. NHS Health Innovation Northwest Cumbria reported in 2024 that reusable surgical gowns had 31% of the carbon footprint of comparable single-use gowns and delivered 45% cost savings per use, which strengthened the business case for institutional adoption. A 2024 BMJ analysis also stated that large U.S. medical centers using reusable PPE programs diverted substantial landfill waste while achieving nearly 50% per-gown cost savings with no measurable impact on infection rates.

Reusable products are projected to expand at an 8.32% CAGR through 2031, which makes them the fastest-growing usability option in the medical protective clothing market. The main barrier is not clinical acceptability, but operational readiness, because facilities need validated processing arrangements before they can scale reuse programs. ISO stated in 2025 that ISO/AWI 25199 was under development to provide guidelines for processing multiple-use healthcare textiles, which could reduce uncertainty for procurement teams reviewing reusable programs. A 2025 study of peri-operative professionals across 134 countries found that misconceptions about the protective performance of reusable gowns remained a major adoption barrier, which shows that education still matters alongside infrastructure. The medical protective clothing market is therefore not moving away from disposables all at once, but it is clearly opening more room for validated reusable pathways.

Complete Report Scope:

• By Product Type
  • Medical Scrubs
  • Surgical Gowns
  • Isolation and Patient Gowns
  • Protective Coveralls and Hazmat Suits
  • Lab Coats
  • Caps, Masks and Shoe Covers
  • Compression and Support Garments
  • Adaptive and Patient Clothing
  • Cleanroom Apparel
• By Usability
  • Disposable
  • Reusable
• By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Out-Patient Clinics
  • Diagnostic and Imaging Labs
  • Home Health and Long-Term Care
  • Dental and Veterinary Clinics
  • Research and Academic Institutes
• By Material
  • Cotton
  • Polyester and Blends
  • Polypropylene (SMS and SMMS)
  • Polyethylene
  • Aramid and High-Performance Blends
  • Antimicrobial-Treated Textiles
  • Smart and Sensor-Integrated Textiles
• By Risk Level
  • Minimal
  • Low
  • Moderate
  • High
• By Distribution Channel
  • Direct Institutional Procurement
  • Distributors and Wholesalers
  • Retail Stores
  • E-Commerce and B2B Platforms
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 38.41% of the medical protective clothing market share in 2025, which made it the largest regional contributor. The region's position rested on high healthcare spending, mature procurement systems, and established gown classification standards tied to ANSI/AAMI PB70 and FDA regulatory pathways. The United States remained the largest country-level market in the region because it concentrated procedure volumes, hospital purchasing power, and formal product credentialing. Canada and Mexico contributed smaller but stable volumes, with demand supported by hospital modernization and steady outpatient expansion. CDC infection control guidance continued to reinforce procedural use of protective apparel across the care system, which supported consistent replacement demand.

Europe remained the second-largest regional block in the medical protective clothing market, with Germany, the United Kingdom, France, and Italy as the main demand centers. Germany benefited from high healthcare spending and an older population, and Destatis reported that 21.5% of the population was aged 65 and above in 2025. The United Kingdom continued to stand out in reusable gown adoption, and NHS Health Innovation Northwest Cumbria documented 45% per-gown cost savings and a 69% carbon footprint reduction versus disposables in 2024. The revised Waste Framework Directive also introduced a new layer of uncertainty for textile producers in Europe, which kept disposal responsibility and product classification under closer review.

Asia-Pacific is projected to expand at a 6.87% CAGR through 2031, which makes it the fastest-growing geography in the medical protective clothing market. China remained the largest manufacturing and demand center within the region, while India continued to expand tertiary care capacity and tighten standards for medical textiles. Japan added a strong demand base through its aging population, and the Statistics Bureau of Japan reported that seniors accounted for 28% of the population in 2024. South Korea supported regional demand through advanced healthcare technology use and a high-quality care environment. South America remained a developing regional opportunity led by Brazil and Argentina, where procurement is becoming more structured after the pandemic period. Middle East and Africa demand was led by GCC healthcare infrastructure investment, while South Africa acted as an anchor market for Sub-Saharan procurement patterns.

1. 3M
2. Ahlstrom Oyj
3. Ansell
4. Careismatic Brands, Inc.
5. Cardinal Health
6. Cintas Corporation
7. DuPont
8. FIGS, Inc.
9. Herculite Products, Inc.
10. Hubei Medlink Healthcare Group
11. Kimberly-Clark Worldwide
12. Lakeland Industries, Inc.
13. Landau Uniforms
14. Medline Industries
15. Molnlycke Health Care
16. O and M Halyard, Inc.
17. Owens and Minor, Inc.
18. Smiths Group
19. STERIS
20. Superior Group of Companies, Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Infection Control Protocols in Hospitals and Ambulatory Care
  • 4.2.2 Expansion of Outpatient and Same-Day Surgical Volumes
  • 4.2.3 Demand for Fluid-Impervious and Antimicrobial Textile Structures
  • 4.2.4 Hospital Shift Toward B2B E-Procurement and Vendor-Managed Inventory
  • 4.2.5 Growth of Adaptive Garments for Geriatric and Bariatric Care
  • 4.2.6 Take-Back and Circular Textile Contracts in Large Health Systems
• 4.3 Market Restraints
  • 4.3.1 Polypropylene and Cotton Price Volatility
  • 4.3.2 Disposal Compliance and Medical Textile Waste Scrutiny
  • 4.3.3 High Certification and Validation Cost for SME Entrants
  • 4.3.4 Counterfeit and Non-Compliant PPE Diluting Buyer Confidence
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Industry Rivalry

5 Market Size & Growth Forecasts

• 5.1 By Product Type
  • 5.1.1 Medical Scrubs
  • 5.1.2 Surgical Gowns
  • 5.1.3 Isolation and Patient Gowns
  • 5.1.4 Protective Coveralls and Hazmat Suits
  • 5.1.5 Lab Coats
  • 5.1.6 Caps, Masks and Shoe Covers
  • 5.1.7 Compression and Support Garments
  • 5.1.8 Adaptive and Patient Clothing
  • 5.1.9 Cleanroom Apparel
• 5.2 By Usability
  • 5.2.1 Disposable
  • 5.2.2 Reusable
• 5.3 By End User
  • 5.3.1 Hospitals
  • 5.3.2 Ambulatory Surgical Centers
  • 5.3.3 Out-Patient Clinics
  • 5.3.4 Diagnostic and Imaging Labs
  • 5.3.5 Home Health and Long-Term Care
  • 5.3.6 Dental and Veterinary Clinics
  • 5.3.7 Research and Academic Institutes
• 5.4 By Material
  • 5.4.1 Cotton
  • 5.4.2 Polyester and Blends
  • 5.4.3 Polypropylene (SMS and SMMS)
  • 5.4.4 Polyethylene
  • 5.4.5 Aramid and High-Performance Blends
  • 5.4.6 Antimicrobial-Treated Textiles
  • 5.4.7 Smart and Sensor-Integrated Textiles
• 5.5 By Risk Level
  • 5.5.1 Minimal
  • 5.5.2 Low
  • 5.5.3 Moderate
  • 5.5.4 High
• 5.6 By Distribution Channel
  • 5.6.1 Direct Institutional Procurement
  • 5.6.2 Distributors and Wholesalers
  • 5.6.3 Retail Stores
  • 5.6.4 E-Commerce and B2B Platforms
• 5.7 By Geography
  • 5.7.1 North America
    • 5.7.1.1 United States
    • 5.7.1.2 Canada
    • 5.7.1.3 Mexico
  • 5.7.2 Europe
    • 5.7.2.1 Germany
    • 5.7.2.2 United Kingdom
    • 5.7.2.3 France
    • 5.7.2.4 Italy
    • 5.7.2.5 Spain
    • 5.7.2.6 Rest of Europe
  • 5.7.3 Asia-Pacific
    • 5.7.3.1 China
    • 5.7.3.2 Japan
    • 5.7.3.3 India
    • 5.7.3.4 Australia
    • 5.7.3.5 South Korea
    • 5.7.3.6 Rest of Asia-Pacific
  • 5.7.4 Middle East & Africa
    • 5.7.4.1 GCC
    • 5.7.4.2 South Africa
    • 5.7.4.3 Rest of Middle East & Africa
  • 5.7.5 South America
    • 5.7.5.1 Brazil
    • 5.7.5.2 Argentina
    • 5.7.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market-level Overview, Core Segments, Financials, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
  • 6.3.1 3M
  • 6.3.2 Ahlstrom Oyj
  • 6.3.3 Ansell Limited
  • 6.3.4 Careismatic Brands, Inc.
  • 6.3.5 Cardinal Health, Inc.
  • 6.3.6 Cintas Corporation
  • 6.3.7 DuPont de Nemours, Inc.
  • 6.3.8 FIGS, Inc.
  • 6.3.9 Herculite Products, Inc.
  • 6.3.10 Hubei Medlink Healthcare Group
  • 6.3.11 Kimberly-Clark Corporation
  • 6.3.12 Lakeland Industries, Inc.
  • 6.3.13 Landau Uniforms
  • 6.3.14 Medline Industries, LP
  • 6.3.15 Molnlycke Health Care AB
  • 6.3.16 O and M Halyard, Inc.
  • 6.3.17 Owens and Minor, Inc.
  • 6.3.18 Smith and Nephew plc
  • 6.3.19 STERIS plc
  • 6.3.20 Superior Group of Companies, Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment